References
- Rudd RA, Aleshire N, Zibbell JE, et al. Increases in drug and opioid overdose deaths-United States 2000–2014. Morb Mortal Wkly Rep. 2016;64:1378–1382.
- Centers for Disease Control and Prevention. Addressing prescription drug abuse in the United States, current activities and future opportunities [Internet]; [cited 2016 Mar 20]. Available from: http://www.cdc.gov/drugoverdose/pdf/hhs_prescription_drug_abuse_report_09.2013.pdf.
- Hill SL, Thomas SH. Clinical toxicology of newer recreational drugs. Clin Toxicol (Phila). 2011;49:705–719.
- Karila L, Megarbane B, Cottencin OM. Synthetic cathinones: a new public health problem. Curr Neuropharmacol. 2015;13:12–20.
- J. Szmuszkovicz. U-50,488 and the к receptor: a personalized account covering the period 1973 to 1990. In: Jucker E, editor. Progress in drug research, vol 52. Basel, Switzerland: Birkhäuser; 1999. p. 167–195.
- U-47700 powder (high purity) [Internet]; [cited 2016 Mar 25]. Available from: https://www.benzochemicals.com/?product=u-47700-powder-high-purity.
- Coopman V, Blanckeart P, Van Parys G, et al. A case of acute intoxication due to combined use of fentanyl and 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700). Forensic Sci Int. 2016;266:68–72.
- Elliott SP, Brandt SD, Smith C. The first reported fatality associated with 9. The synthetic opioid 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700) and implications for forensic analysis. Drug Test Anal. 2016. [Epub ahead of print]. doi:10.1002/dta.1984.
- Loew G, Lawson J, Toll L, et al. Structure activity studies of two classes of beta-amino-amides: the search for kappa-selective opioids. NIDA Res Monogr. 1988;90:144–151.
- Cheney BV, Szmuszkovicz J, Lahti RA, et al. Factors affecting binding of trans-N-[2-(methylamino)cyclohexyl]benzamides at the primary morphine receptor. J Med Chem. 1985;28:1853–1864.
- Harper NJ, Veitch GBA, Wibberley DG. 1-(3,4 Dichlorobenzamido-methyl)cyclohexyldimethylamine and related compounds as potential analgesics. J Med Chem. 1974;17:1188–1193.
- Cottencin O, Rolland B, Karila L. New designer drugs (synthetic cannabinoids and synthetic cathinones): review of literature. Curr Pharm Des. 2014;20:4106–4111.
- Stogner JM. The potential threat of acetyl fentanyl: legal issues, contaminated heroin, and acetyl fentanyl “disguised” as other. Ann Emerg Med. 2014;64:637–639.
- Katselou M, Papoutsis I, Nikolaou P, et al. AH-7921: the list of new psychoactive opioids is expanded. Forensic Toxicol. 2015;33:195–201.
- Novel opioid, U-47700 [Internet]; [cited 2016 Mar 25]. Available from: http://www.bluelight.org/vb/threads/739960-Novel-opioid-U-47700.
- New designer opioid: U-47700 [Internet]; [cited 2016 Mar 25]. Available from: https://drugs-forum.com/forum/showthread.php?t=267116.
- [31 new substances can be classified as a narcotic or danger to health] Original title: 31 nya ämnen kan klassas som narkotika eller hälsofarlig vara (in Swedish). Folkhälsomyndigheten. November 2015 [Internet]; [cited 2016 Mar 25]. Available from: http://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2015/november/31-nya-amnen-kan-klassas-som-narkotika-eller-halsofarlig-vara/.